Modulation of Inflammation by Plant-Derived Nutraceuticals in Tendinitis

Tendinitis (tendinopathy) is a pro-inflammatory and painful tendon disease commonly linked with mechanical overuse and associated injuries, drug abuse, and lifestyle factors (including poor diet and physical inactivity) that causes significant healthcare expenditures due to its high incidence. Nuclear factor kappa B (NF-κB) is one of the major pro-inflammatory transcription factors, along with other inflammation signaling pathways, triggered by a variety of stimuli, including cytokines, endotoxins, physical and chemical stressors, hypoxia, and other pro-inflammatory factors. Their activation is known to regulate the expression of a multitude of genes involved in inflammation, degradation, and cell death. The pathogenesis of tendinitis is still poorly understood, whereas efficient and sustainable treatment is missing. Targeting drug suppression of the key inflammatory regulators represents an effective strategy for tendinitis therapy, but requires a comprehensive understanding of their principles of action. Conventional monotherapies are often ineffective and associated with severe side effects in patients. Therefore, agents that modulate multiple cellular targets represent therapeutic treatment potential. Plant-derived nutraceuticals have been shown to act as multi-targeting agents against tendinitis via various anti-oxidant and anti-inflammatory mechanisms, whereat they were able to specifically modulate numerous signaling pathways, including NF-κB, p38/MAPK, JNK/STAT3, and PI3K/Akt, thus down-regulating inflammatory processes. This review discusses the utility of herbal nutraceuticals that have demonstrated safety and tolerability as anti-inflammatory agents for the prevention and treatment of tendinitis through the suppression of catabolic signaling pathways. Limitations associated with the use of nutraceuticals are also described.


Introduction
Tendinopathy is a frequently occurring and very complex disease, restricting the daily lives of many people worldwide due to symptoms such as severe pain and immobility [1][2][3][4]. The reasons for development of tendinopathies or tendon injuries are diverse, ranging from tendon rupture and trauma-associated damage to mechanical stress and overuse to lifestyle factors (including poor diet or lack of exercise), accompanied by inflammation and inflammation-linked processes [5][6][7][8]. It is well known that inflammation is a major cause of many chronic diseases, including cancer, neurological, metabolic, cardiovascular, and skeletal disorders, including tendinitis among many others ( Figure 1). Therefore, targeting inflammation is fundamental to the prophylaxis, therapy, and treatment of tendinitis [9]. Moreover, one of the main players in cellular inflammatory processes is the master pro-inflammatory transcription factor, nuclear factor kappa B (NF-κB), which is triggered by different cytokines, such as the tumor necrosis factor (TNF)-α, TNF-β, ment of tendinitis [9]. Moreover, one of the main players in cellular inflammatory processes is the master pro-inflammatory transcription factor, nuclear factor kappa B (NF-κB), which is triggered by different cytokines, such as the tumor necrosis factor (TNF)-α, TNF-β, or interleukin (IL)-1β, and, when activated, leads to further expression and upregulation of pro-inflammatory genes and catabolic enzymes, contributing to the pathogenesis of tendinitis by further fuelling inflammation and tissue degradation in tendon [10][11][12]. So, based on the fact that NF-κB and other signaling pathways, such as p38/MAPK, JNK/STAT3, and PI3K/Akt, are known to regulate more than 500 genes involved in inflammation and associated processes, they demonstrate potential targets to lower the level of inflammation in tendinitis treatment, which is currently still lacking in efficiency or safety [10,[12][13][14][15][16][17][18]. Current standard treatment strategies of tendinitis mainly follow the application of oral non-steroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids [19,20], whereas NSAIDs mainly act as analgesics and inflammation-targeting agents, inducing the inhibition of cyclooxygenase (COX) and prostaglandin endoperoxide synthase enzymes as main pharmacological targets that are regulators of prostaglandin biosynthesis, which in turn are strongly involved in inflammation [21,22]. Glucocorticoids also fight inflammation through diverse immune-suppressive and anti-inflammatory actions, such as downregulating signal transduction downstream of several pro-inflammatory pathway receptors, inhibiting lymphocyte activity, and proliferating or modulating the innate immunity [23,24]. Both NSAIDs and glucocorticoids frequently lead to severe side effects in patients [21,22,25], including organ damages of the gastrointestinal tract, as well as hepatic, renal, cardiovascular, or pulmonary complications [22,26]. In addition, tendon's ability to regenerate, partly via the synthesis of proteoglycans and collagen, as major constituents of tenocytes and their extracellular matrix (ECM), has been found to be greatly reduced following application of NSAIDs and corticosteroids [27][28][29][30]. This clearly underscores the need for clinically safe and efficacious new anti-inflammatory agents. Current standard treatment strategies of tendinitis mainly follow the application of oral non-steroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids [19,20], whereas NSAIDs mainly act as analgesics and inflammation-targeting agents, inducing the inhibition of cyclooxygenase (COX) and prostaglandin endoperoxide synthase enzymes as main pharmacological targets that are regulators of prostaglandin biosynthesis, which in turn are strongly involved in inflammation [21,22]. Glucocorticoids also fight inflammation through diverse immune-suppressive and anti-inflammatory actions, such as downregulating signal transduction downstream of several pro-inflammatory pathway receptors, inhibiting lymphocyte activity, and proliferating or modulating the innate immunity [23,24]. Both NSAIDs and glucocorticoids frequently lead to severe side effects in patients [21,22,25], including organ damages of the gastrointestinal tract, as well as hepatic, renal, cardiovascular, or pulmonary complications [22,26]. In addition, tendon's ability to regenerate, partly via the synthesis of proteoglycans and collagen, as major constituents of tenocytes and their extracellular matrix (ECM), has been found to be greatly reduced following application of NSAIDs and corticosteroids [27][28][29][30]. This clearly underscores the need for clinically safe and efficacious new anti-inflammatory agents.
In this review, we will present different natural occurring agents that have currently been demonstrated to show efficiency in the treatment of tendinitis and tendon regeneration, describing their individual modes of action to better understand their potential for inflammation-related tendinitis therapy.

Signaling Pathways in Inflammation and Inflammation-Associated Diseases
As of recent, it is widely known that chronic diseases, such as RA, inflammatory bowel diseases (IBD), different types of cancer, OA, COPD, cardiovascular and neurological disorders, and many more, are mostly associated with inflammation that turned into a long-running condition, exposing the host's immune system to a permanent state of stress [9,66,67]. Inflammation in chronic diseases is part of the immune response to pathogenic conditions in the human organism that is mediated by various molecular mechanisms and can be triggered by a wide range of conditions, including environmental factors, lifestyle, diet, and overall activity [68]. Major signaling pathways that contribute to an inflammatory environment when being dysregulated are p38/MAPK, IL-6/JAK/STAT3, and PI3K/Akt, as well as the NF-κB signaling pathway [67].

p38/MAPK Signaling Pathway
The p38 mitogen-activated protein kinase (MAPK) functions together with other MAPK family members, as a cellular signal transducer for external stimuli, and mediates a wide range of cellular responses. P38/MAPK is stimulated by pro-inflammatory and stressful stimuli, such as TNF-α, IL-1β, or lipopolysaccharides, by binding to and activating various receptors, including G-protein-coupled receptors (GPCRs), toll-like receptors (TLRs), cytokine receptors, growth factor receptors, and other receptors linked to environmental stress [66,67,69]. The upstream activation of p38/MAPK by MAPK kinases (MAPKK) in turn plays a pivotal role in the release of various pro-inflammatory cytokines, such as IL-6, IL-1, IL-8, or TNF-α, and also leads to the induction of inflammation-involved enzymes, such as COX-2 and inducible nitric oxide synthase (iNOS), as well as the activation of matrix metalloproteinases (MMPs) and the modulation of receptor activator of NF-κB ligand (RANKL) expression, which is essential for osteoclastogenesis and bone resorption. Thus, targeting the p38/MAPK pathway demonstrates a promising strategy in the treatment of inflammatory diseases, especially in musculoskeletal disorders, such as OA or osteoporosis, because of RANKL modulating potential ( Figure 2) [66,67,[70][71][72][73]. Under physiological conditions, NF-κB is located as a heterodimeric complex of p50 and p65 bound to its inhibitor IκBα in the cytoplasm. The upstream IKK complex can activate IκBα by its phosphorylation and ubiquitin-dependent degradation, leading to NF-κB release that is then activated (p65-NF-κB) and translocates into the nucleus to activate the transcription of target genes, including cytokines and pro-inflammatory enzymes. The activation of the p38/MAPK signaling pathway by upstream MAPKK is promoted by external stimuli linked to stress and inflammation, binding to various receptors. Activated p38 in turn results in the transcription of several pro-inflammatory genes, such as COX-2, iNOS, MMPs, or RANKL, which are strongly involved in tissue remodeling. Another major signaling pathway involved in inflammation, the JAK/STAT3 pathway, is activated by IL-6, consequently inducing STAT3 phosphorylation and activation, which then translocates to the nucleus, where it regulates the expression of many genes linked to apoptosis, inflammation, and tissue degradation, such as Bcl-XL, COX-2, and various cytokines. Abbreviations: COX-2; cyclooxygenase-2, IκBα; NF-κB inhibitor alpha, IKK; IκB kinase, IL-1 β; Interleukin 1 beta, iNOS; inducible nitric oxide synthase, JAK; Janus kinase, MAPKK; MAPK kinase, MAPKKK; MAPKK kinase, MMPs; matrix metalloproteinases, PARP; Poly(ADP-Ribose)-Polymerase, RANKL; receptor activator of NF-κB ligand, STAT3; signal transducer and activator of transcription 3, TNF-α; tumor necrosis factor alpha, TNF-β; tumor necrosis factor beta.

IL-6/JAK/STAT3 Signaling Pathway
In another major signaling pathway involved in inflammation, the IL-6/JAK/STAT3 pathway, Janus kinase (JAK), a non-receptor cytoplasmic tyrosine kinase, is activated by the pro-inflammatory cytokine IL-6 that is often found in enhanced levels in chronic disorder patients, finally leading to the phosphorylation and activation of the signal transducer and activator of transcription 3 (STAT3) which, in turn, translocates into the nucleus and regulates expression of genes that are involved in cell differentiation and proliferation among other cellular functions, such as cyclin D, Bcl-XL, COX-2, vascular endothelial growth factor (VEGF), and cytokines [67]. The hyperactivation of STAT3 signaling has been observed in most human cancer cases, and abnormal levels of IL-6, stimulating STAT3, are commonly found in patients suffering from chronic disease, such as IBD or RA. Moreover, STAT3 contributes to the promotion of other inflammatory pathways and is highly interconnected with NF-κB signaling, co-regulating a wide range of pro-inflammatory genes ( Figure 2) [74][75][76][77]. . Molecular backgrounds of NF-κB, STAT3, p38/MAPK signaling linking inflammation, and degradation. Under physiological conditions, NF-κB is located as a heterodimeric complex of p50 and p65 bound to its inhibitor IκBα in the cytoplasm. The upstream IKK complex can activate IκBα by its phosphorylation and ubiquitin-dependent degradation, leading to NF-κB release that is then activated (p65-NF-κB) and translocates into the nucleus to activate the transcription of target genes, including cytokines and pro-inflammatory enzymes. The activation of the p38/MAPK signaling pathway by upstream MAPKK is promoted by external stimuli linked to stress and inflammation, binding to various receptors. Activated p38 in turn results in the transcription of several proinflammatory genes, such as COX-2, iNOS, MMPs, or RANKL, which are strongly involved in tissue remodeling. Another major signaling pathway involved in inflammation, the JAK/STAT3 pathway, is activated by IL-6, consequently inducing STAT3 phosphorylation and activation, which then translocates to the nucleus, where it regulates the expression of many genes linked to apoptosis, inflammation, and tissue degradation, such as Bcl-X L , COX-2, and various cytokines. Abbreviations: COX-2; cyclooxygenase-2, IκBα; NF-κB inhibitor alpha, IKK; IκB kinase, IL-1 β; Interleukin 1 beta, iNOS; inducible nitric oxide synthase, JAK; Janus kinase, MAPKK; MAPK kinase, MAPKKK; MAPKK kinase, MMPs; matrix metalloproteinases, PARP; Poly(ADP-Ribose)-Polymerase, RANKL; receptor activator of NF-κB ligand, STAT3; signal transducer and activator of transcription 3, TNF-α; tumor necrosis factor alpha, TNF-β; tumor necrosis factor beta.

IL-6/JAK/STAT3 Signaling Pathway
In another major signaling pathway involved in inflammation, the IL-6/JAK/STAT3 pathway, Janus kinase (JAK), a non-receptor cytoplasmic tyrosine kinase, is activated by the pro-inflammatory cytokine IL-6 that is often found in enhanced levels in chronic disorder patients, finally leading to the phosphorylation and activation of the signal transducer and activator of transcription 3 (STAT3) which, in turn, translocates into the nucleus and regulates expression of genes that are involved in cell differentiation and proliferation among other cellular functions, such as cyclin D, Bcl-X L , COX-2, vascular endothelial growth factor (VEGF), and cytokines [67]. The hyperactivation of STAT3 signaling has been observed in most human cancer cases, and abnormal levels of IL-6, stimulating STAT3, are commonly found in patients suffering from chronic disease, such as IBD or RA. Moreover, STAT3 contributes to the promotion of other inflammatory pathways and is highly inter-

NF-κB Signaling Pathway
In this context, NF-κB has been found as a major initiator of pro-inflammatory cascades and mechanisms ( Figure 2) [82]. Under resting conditions, NF-κB is located as a heterodimeric complex consisting of p50 and p65 in a latent state in the cytoplasm, bound to its natural inhibitor nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha (IκBα) [83,84]. As a regulator of the NF-κB signaling pathway, the IκB kinase (IKK) complex can activate IκBα by its phosphorylation and ubiquitin-dependent degradation, releasing NF-κB that is then able to translocate into the nucleus in its active form (p-NF-κB), where it binds to specific consensus sequences and activates the transcription of various target genes (canonical pathway) ( Figure 2). Most of the proteins that are encoded by NF-κB target genes are part of the host's immune response, such as cytokines (e.g., TNF-α, TNF-β, IL1-β), pro-inflammatory enzymes, as well as stress responsive genes (e.g., MMPs, COX-2, RANKL, caspase-3, PARP) [85][86][87][88]. A variety of those genes activated by NF-κB, such as TNF-α, TNF-β, IL-1, and IL-8, in turn activate NF-κB signaling again, building a positive feedback loop by continuously stimulating inflammation and enhancing stress responses [82,87]. Moreover, NF-κB signaling can be activated by many other stimuli, including different growth factors, viral and bacterial antigens, radiation, or reactive oxygen species (ROS), binding to and being recognized by the TNF receptor superfamily or TLRs [82,87,88]. However, NF-κB can also be induced via the non-canonical pathway which is based on processing p100 NF-κB members via the NF-κB-inducing kinase as a central operator, finally generating heterodimers p52 and RelB which translocate into the cell nucleus to induce target gene transcription. The non-canonical NF-κB pathway, which shows a rather slow character compared to the rapid canonical pathway, is mainly induced by TNF ligands binding to their receptor. Most of them also stimulate the canonical pathway of NF-κB initiation and regulate processes that include the functional linkage of both NF-κB pathways. However, dysregulation of the non-canonical NF-κB pathway has also been demonstrated to play a crucial role in the pathogenesis of inflammatory diseases [12,86,89]. Therefore, one main target to fight inflammation is modulating the NF-κB signaling pathway, which is known as the master regulator of inflammation and holds sway over many molecular processes [12,83,88,90].

Plant-Derived Nutraceuticals and Inflammation
In recent decades, nutraceuticals, i.e., so-called functional foods, have gained increasing interest worldwide. This was not only due to their great health-promoting antiinflammatory potential, but also due to the low or even no toxic effects in administration compared to standard synthetic medicals [91]. Especially with regard to inflammation and inflammation-associated diseases, such as cancer, RA, IBD, the metabolic syndrome, and cardiovascular or neurological disorders, among many others, various nutraceuticals have been found to reveal inflammation-protective properties [92][93][94][95][96][97][98]. These properties were found in earlier research to rely, at least in part, on the ability of a wide range of polyphenols to target and modulate a number of pro-inflammatory transcription factors, including NF-κB. As NF-κB signaling has been described as a major contributor to inflammation in detail before, the great potential of plant-derived NF-κB targeting nutraceuticals becomes obvious [10,36,54,[99][100][101][102][103][104].
As an example, it has been demonstrated that phenolic acids of blueberries exhibited anti-inflammatory effects by targeting NF-κB and suppressing TNF-α and IL-6 production, thus demonstrating great potential in the fight against chronic diseases, such as diabetes, cardiovascular and neurodegenerative disease, and several more [105][106][107]. In addition, targeting NF-κB and STAT3 signaling, as well as pathway-dependent gene end products, is known to be promoted by turmeric extract curcumin, what has been proven in a wide range of different studies investigating on Alzheimer's disease, cancer, musculoskeletal disorders, or ulcerative colitis, among many others [54,[108][109][110][111][112][113][114]. Furthermore, Lactucin, a bio-active component found in endive, chicory, and romaine lettuce, has been shown to target pro-inflammatory STAT3 in order to suppress adipogenesis in obesity and obesitylinked complications [115], whereas NF-κB was blocked by Lactucin in cancer cells [116]. Moreover, other signaling pathways that have been described to play an essential role in inflammation, such as MAPK, were shown to be modulated by polyphenols, e.g., resveratrol or epigallocatechin-3-gallate (EGCG), which abolished inflammation and ROS by the functional blockade of p38/MAPK in RA [93,117]. In addition, the PI3K signaling pathway has been shown to be inhibited by the flavonoid quercetin with a simultaneous decrease in IL-1β and IL-6 levels, as well as by resveratrol, showing the neuro-and tendinitis-protective effects following down-regulation of the PI3K signaling pathway [14,94,118].
Besides these examples, the range of polyphenols that have been shown to modulate major inflammatory pathways, pathway-dependent effector molecules, and gene expression is huge and include calebin A, kaempferol, anthocyanins, genistein, various phenolic acids, caffeine, allicin, cinnamon polyphenols, and many more [14,36,[119][120][121][122][123]. This demonstrates their great potential for preventing and treating the inflammation and pathogenesis of chronic diseases, and explains their great anti-inflammatory properties and anabolic effects [56,124].
In the following section, we will describe the anti-inflammatory activities of polyphenols focusing on tendinitis.

Plant-Derived Nutraceuticals in the Treatment of Tendinitis
With regard to chronic musculoskeletal disorders, such as RA, osteoporosis, or OA, various polyphenols have been found to reduce inflammation and, in addition, exhibit tissue-protective and regeneration-stimulating effects [36,92,93,125] due to their ability to modulate dysregulated pro-inflammatory pathways back to physiological conditions, and, more so, to stimulate anabolic processes in the respective tissues, helping them to regenerate and heal [36,[126][127][128][129]. Additionally, in tendinitis, as a very common and painful condition disabling musculoskeletal functionality and still lacking sustainable treatment, various plant-derived compounds have been demonstrated to affect inflammation and promote tissue healing, thus representing promising bio-active treatment agents in tendinitis therapy [10,14,36,62,65,[130][131][132][133]. Since plant-derived nutraceuticals are ingredients of a large number of vegetables, spices, and fruit, they can be easily integrated into people's daily diet while being cost-effective [134][135][136]. Moreover, many nutraceuticals are available in the form of dietary supplements in various forms, such as pills or sachets. However, poor bioavailability of some compounds is frequently being mentioned, e.g., due to poor absorption ability, fast systemic metabolism, and elimination or low solubility, among other factors that could contribute to the limiting effects of nutraceuticals in their administration [135,137,138]. Nevertheless, due to their high potential in many inflammation-associated diseases, such as tendinitis, it is reasonable to study their pharmacological effects.

Modulation of Inflammatory Pathways in Tendinitis
In tendinitis, as in other chronic diseases, inflammatory pathways and mediators are abnormally activated, which leads to further fuelling of the inflammatory environment, and finally to the chronification and degeneration of tissue [4,139,140]. Therefore, targeting these biological pathways underlying inflammation is assumed to be a very effective strategy to break through catabolic events in tendon tissue [10,56,141,142]. As of recent, various polyphenols have been proven to show inflammation-protective activity in disordered tendon tissue, including compounds of turmeric, calebin A and curcumin, green tea extracts, various flavones, pineapple extract bromelain, boswellia acid, and resveratrol, among several others [10,14,36,130,[143][144][145]. The main target pathways that have been found to be modulated by nutraceuticals specifically in tendinitis are NF-κB, STAT3, PI3K, and associated pathway dependent gene products (such as MMPs, COX-2, and caspase-3), as well as stimulated cytokines, including IL-1β, TNF-α, and TNF-β ( Figure 3) [10,36,132,146,147]. With nutraceuticals targeting NF-κB, translocation from cell cytoplasm into the nucleus is suppressed, inhibiting its activation. As a consequence of NF-κB being inactivated, further downstream cascades, leading to inflammation and apoptosis, are down-regulated as well. For example, in tendinitis, Bcl-2 and Bax have been found to be affected, which play an essential role in cell apoptosis [10]. In addition, cytokines stimulating NF-κB, and, in turn, being promoted by NF-κB such as TNF-α, TNF-β, or IL-1β, were shown to be inhibited, whereas the activity of other apoptosis-promoting enzymes, such as caspase-3, was also found to be down-regulated by nutraceuticals in tendinitis, probably due to NF-κB modulation [14,54,148,149]. In the context of nutraceutical-induced NF-κB modulation, COX-2 inhibition as well as alterations in MMP activity patterns have also been observed in tendon, which are not only of high relevance for inflammation, but also for tissue remodeling processes, making them another great target in tendon regeneration therapy [146,[149][150][151][152].
Nutrients 2022, 14, x FOR PEER REVIEW 7 of 30 their administration [135,137,138]. Nevertheless, due to their high potential in many inflammation-associated diseases, such as tendinitis, it is reasonable to study their pharmacological effects.
In addition, it has been observed that with the down-regulation of inflammatory pathways, simultaneously anabolic cascades, such as tendon-specific transcription factor scleraxis promotion, can be stimulated by nutraceuticals that act in tandem, thus demonstrating the great healing potential for tendinitis [36]. Overall, the number of cascades originated by the major players of inflammation, such as NF-κB, STAT3, PI3K, and MAPK, shows the great potential in targeting them in inflammation-associated diseases, such as tendinitis, which certain nutraceuticals have already been shown to be capable of.
In addition, it has been observed that with the down-regulation of inflammatory pathways, simultaneously anabolic cascades, such as tendon-specific transcription factor scleraxis promotion, can be stimulated by nutraceuticals that act in tandem, thus demonstrating the great healing potential for tendinitis [36]. Overall, the number of cascades originated by the major players of inflammation, such as NF-κB, STAT3, PI3K, and MAPK, shows the great potential in targeting them in inflammation-associated diseases, such as tendinitis, which certain nutraceuticals have already been shown to be capable of.

Plant-Derived Compounds Proposed for Tendinitis Treatment
Within this chapter, we will describe different natural compounds and polyphenols that have been studied in the context of tendinitis, tendon tissue, and inflammation ( Table  1). The chemical structures of some compounds are shown in Figure 4.

Avocado/Soybean Unsaponifiables
Avocado and soybean unsaponifiables (ASUs) are made of oils extracted from fruit and seeds of avocado and soybean that exhibit active anti-inflammatory properties; thus, they are recommended as supplementary treatment in inflammation-linked chronic diseases, such as OA [153][154][155][156]. In a recent study by Grzanna et al., the effects of ASU have been examined in IL-1β-induced inflammation horse tenocytes. ASUs were concomitantly administered with glucosamine (GLU) and chondroitin sulfate (CS), because this mixture has been used in osteoarthritis joint-inflammation therapy before. As a result of the study,

Avocado/Soybean Unsaponifiables
Avocado and soybean unsaponifiables (ASUs) are made of oils extracted from fruit and seeds of avocado and soybean that exhibit active anti-inflammatory properties; thus, they are recommended as supplementary treatment in inflammation-linked chronic diseases, such as OA [153][154][155][156]. In a recent study by Grzanna et al., the effects of ASU have been examined in IL-1β-induced inflammation horse tenocytes. ASUs were concomitantly administered with glucosamine (GLU) and chondroitin sulfate (CS), because this mixture has been used in osteoarthritis joint-inflammation therapy before. As a result of the study, it has been demonstrated that ASU was able to significantly suppress IL-1β-induced inflammation and to reduce COX-2 and prostaglandin E2 expression, indicating that ASU can act as a potential treatment agent in tendon-associated inflammation for combination therapy with GLU and CS (Table 1) [157]. However, because of the small number of studies conducted with ASU in the context of tendinitis, these results must be considered as an only vague hint of ASU's potential in tendinitis treatment and further research has to be carried out.

Bromelain
Bromelain is a natural complex of proteolytic enzymes that are derived from fruit or stem of the Ananas cosmosus (pineapple). It has been used as another phytopharmaceutical in folk medicine for centuries due to its anti-inflammatory, anti-cancer, immune-modulating, as well as anti-thrombotic properties, to name just a few, as well as its safety for administration [158][159][160]. In musculoskeletal injuries or disorders, it is also known to reduce acute pain and swelling [161]. In a study by Aiyegbusi et al., the effects of aqueous extracts of different parts of the pineapple plant were investigated on tenocyte proliferation in rats in vivo after crush injury of the Achilles tendon. In addition, the tendon malondialdehyde (MDA) level, which is a marker of oxidative stress, was analyzed [161,162]. Finally, the extracts of pineapple flesh and bark were found to promote the proliferation of tenoblasts, comparable to untreated tendon, whereas leaves and core extracts negatively affected the proliferation of tenocytes. Using the pineapple flesh extract, even the MDA level in tendon could be alleviated, suggesting that the anti-oxidant properties of the pineapple are located in its flesh, while both flesh and bark showed the potential to promote tendon regeneration and injury healing by promoting tenoblast proliferation [161]. The proliferation-stimulating properties of bromelain in tendon were supported by further studies in rats, arguably due to the role for ROS, or, on the other hand, the increased expression of platelet activating factor (PAF) by modulating the cytokine system, leading to the proliferation of tenoblasts [130,163].

Curcuminoids
Curcuminoids ( Figure 4) describe a group of bio-active nutraceutical compounds found in the rhizome of turmeric (Curcuma longa) that exhibit considerable inflammationprotective and anti-oxidant properties and have a long history in traditional Ayurvedic and Chinese medicine [34,35,[164][165][166].

Curcumin
Curcumin is the most abundant polyphenolic compound found in the group of curcuminoids that gives turmeric its characteristic intensive yellow colour [167]. Due to its multiple health-beneficial effects in a wide range of chronic diseases, including RA, OA, cancer, neurological, cardiovascular or respiratory disorders, it has reached a lot of attention as an anti-inflammatory agent in therapy [35,54,111,127,167]. As a wellknown curcuminoid, curcumin has also been widely investigated in the context of tendon and tendinitis in several studies, where it was proven to stimulate tendon vitality and regeneration [10,64,131,146,[168][169][170][171]. For instance, in previous in vitro research using human tenocyte cultures, it was found that curcumin was able to suppress NF-κB activation triggered by IL-1β through inhibition of IκBα and NF-κB -dependent pro-inflammatory COX-2 and MMPs as well as Bcl-2, Bcl-xL and TRFA-1 that are involved in apoptosis. Moreover, it was demonstrated that these effects were at least partly executed by downregulation of PI3K/Akt signaling promoted by curcumin, suggesting the polyphenol as an effective treatment option for tendinitis as well as for prophylaxis by its modulation of pro-inflammatory NF-κB signaling [10]. The strong anti-inflammatory effect of curcumin was also found in a recent in vivo study by Chen et al., demonstrating the down-regulation of pro-inflammatory ROS, TNF-α, IL-1β and MMPs in rats during curcumin treatment in the form of curcumin/Mg 2+ hydrogels as well [146].
In addition, in a study by Sajithlal et al. investigating the preventive and therapeutic potential of curcumin in tail tendon of diabetic rats, it has been demonstrated that curcumin treatment significantly reduced oxidative stress by the suppression of lipid peroxidation and even more, prevented increased accumulation of advanced glycation end products and collagen crosslinking in tendon as an issue coming along with diabetes [168]. In another study, of diabetic rats similar observations were made using tetrahydro-curcumin (a metabolite of curcumin) for treatment [172], showing curcumins potential in tendonassociated therapy as an effective anti-oxidant [168,172]. Besides its anti-inflammatory effects, curcumin has also been proven in vitro (human tenocytes) and in vivo (rats) to help in tendon regeneration and healing by promoting collagen I and II synthesis [10,170] and their organization as filaments enhancing tendons biomechanical traits [64] as well as by suppressing the peritendinous adhesion of inflammatory products [169]. Moreover, curcumin has been shown to prevent tendon calcification in rats as a common issue of latestage tendinitis due to aberrant tendon stem and progenitor cells osteogenic differentiation triggered by inflammation, by promoting tenogenesis while suppressing osteogenesis at the respective pathological sites [131], as summarized in Table 1.

Calebin A
Besides curcumin, another bio-active compound of turmeric, namely calebin A, has been recently investigated in in vitro tendinitis study models by our group. Within our study, calebin A was demonstrated with the ability to suppress inflammatory conditions in tenocytes by inhibiting the NF-κB signaling pathway and its associated gene end products, such as COX-2, MMP-9, and caspase-3, which are responsible for matrix degrading and apoptotic processes, leading to tissue inflammation and degeneration. By suppressing these catabolic events, calebin A helps in inflammation protection and tendon regeneration, which was shown by an increased expression of tendon-specific transcription factor scleraxis, tenomodulin, as well as collagen I. The down-regulation of NF-κB with the simultaneous up-regulation of tenogenic scleraxis indicates a multi-modulatory effect of calebin A in tendinitis by targeting the NF-κB-scleraxis axis (Table 1) [36].
Therefore, calebin A represents another powerful nutraceutical with great potential in tendinitis therapy, as well as in its prevention. However, further studies are needed to examine the full potential of the natural compound calebin A in fighting inflammatory and degrading processes in tendinitis [36].

Green Tea Extracts (Epigallocatechin Gallate)
Epigallocatechin gallate (Figure 4), as the most abundant polyphenol component of green tea, has been shown to be beneficial in many different diseases, including cancer, the metabolic syndrome, and neurodegenerative disorders, because of its anti-oxidant and anti-inflammatory characteristics [173][174][175]. These effects were also found in a study investigating human tendon-derived fibroblasts in vitro, in which EGCG administration suppressed IL-1β-stimulated collagenase and stromelysin, as well as the expression of MMPs, and simultaneously reduced the stimulation of p54/JNK/SAPK phosphorylation. Altogether, these outcomes suggest ECM breakdown as an important target for EGCG and other green tea polyphenols, thus proposing a potential target for EGCG therapy in tendon injury [148]. In addition to that, green tea extract has also been shown to remarkably reduce glycation, i.e., the resulting formation of advanced glycation end products (AGE), as well as crosslink collagen in the tail tendon of diabetic rats. These outcomes demonstrate the therapeutic potential of green tea extracts in treating diabetes-related tendon glycation, since the formation of glycation and AGE in tendon finally leads to impaired tendon turnover, making it even more vulnerable to tendinitis [145]. Furthermore, in an in vivo study by Rutter et al., it has been demonstrated that green tea polyphenols could prevent collagen aging markers from rising and to even delay collagen crosslinking by anti-oxidant mechanisms in rats, further supporting green tea extract as a promising anti-glycation agent. These effects could be even enhanced by the concomitant supplementation of vitamin C and E [176]. Besides their anti-oxidant mechanisms, green tea polyphenols are able to stimulate recovery processes during tendinitis, as shown by the promotion of ECM components and glycosaminoglycans, among other recovery elements after Achilles tendinitis in rats, in combination with a glycine diet. In addition, the synthesis of collagen I as a crucial constituent of tendon was remarkably enhanced by green tea treatment. Simultaneously, inflammatory pathways were modulated in the form of decreased MMP-9 levels, which is important for the remodeling of tissue, whereas MMP-2 and IL-1β, both involved in the active remodeling process, remained elevated during green tea treatment, indicating the potential of green tea polyphenols to accelerate tendon tissue remodeling and the regeneration after tendinitis [132,177]. Altogether, several studies indicate that green tea extracts and EGCG represent promising agents when it comes to fighting ROS and inflammation-triggering stimuli, as well as inflammation itself in tendon tissue (Table 1). However, further research and clinical trials have to be conducted in the future for validation purposes.

Flavonoids/Flavones
Flavonoids and flavones ( Figure 4) comprise a group of secondary metabolites that are present in a variety of plants, such as celery, parsley, red pepper, chamomile, mint or gingko bilboa, and citrus fruit, and are known to exhibit anti-inflammatory and associated properties in a wide range of chronic diseases [178][179][180][181].

Anthocyanin
In an in vitro study model of rotator cuff-derived tenofibroblasts, the effect of flavonoid anthocyanin extracted from the black soybean (Glycine max (L.) MEER) as anti-oxidants was observed, thus reducing apoptosis in oxidation-stressed tenofibroblasts. Moreover, the suppression of activation of ERK1/2 and JNK accompanied by decreased ROS levels has been assumed to be an important mechanism in the effect of anthocyanins, as, in contrast, ERK1/2 and JAK were up-regulated in H 2 O 2 -induced apoptotic tenofibroblast cultures without anthocyanin treatment, indicating anthocyanins therapeutic potential in rotator cuff tendon that is exposed to oxidative stressors (Table 1) [133].

Eriocitrin
In previous research by Shang et al., eriocitrin, as another flavonoid derived from lemon and limes, was investigated for its potential as a bio-active reagent in tendon stem cells in vitro. Eriocitrin that has been described as the most potent anti-oxidant in citrus fruits was found to stimulate tendon stem cell proliferation and to enhance their migration activity, as an important feature of tissue healing and regeneration [147,182,183]. In addition, not only could pro-apoptotic caspase-3 activity be reduced in a concentration-dependent manner, but also the extent of scar formation, determined by scar-formation-related markers fibronectin and biglycan, could be markedly reduced in tenocyte stem cells when treated with eriocitrin, making it another promising plant-derived agent in tendinitis therapy (Table 1) [147].

Genistein
In the context of estrogen deficiency, as experienced in menopause, which consequently promotes a loss of collagen and increases the risk of tendinopathies, the flavone and phyto-oestrogen genistein was investigated on collagen synthesis and Achilles tendon in ovariectomized rats in previous research [184][185][186]. Ramos et al. found evidence that genistein was able to prevent collagen loss in the Achilles tendon of rats in a postmenopausal state, underlining its potential for reducing tendinitis risk in women undergoing estrogen deficiency [184]. Moreover, it has been recently demonstrated that genistein improved functional features of Achilles tendon in estrogen-deficient rats, mostly by modulating proliferation-related gene expression (tenomodulin, proliferating cell nuclear antigen (Pcna)), as opposed to collagen remodeling (Table 1) [185]. However, further studies have to be conducted in the future to verify this hypothesis.

Icariin
Icariin is the most abundant flavonoid in horny goat weed (Epimedium grandiflorum) and has been demonstrated to positively affect bone metabolism, regeneration, and density [187,188]. In a study by Ye et al., flavonoids have been shown to also support the healing and repair of tendon after rotator cuff reconstruction in rats in vivo, mainly by stimulating the synthesis of collagen type I and II. Moreover, the inhibition of bone loss and the promotion of osteogenesis and angiogenesis, as shown by vascular staining, clearly demonstrating enhanced CD31 (platelet endothelial cell adhesion molecule) and VEGF expression as a sign for intrinsic neovascularization around the tendon insertion site through icariin treatment, are assumed to be crucial components for tendon-bone healing (Table 1) [189]. On this background, icariin represents another flavonoid with therapeutic potential when it comes to tendinitis and tendon-associated issues, but still, cellular and molecular mechanisms have to be investigated in the future.

Quercetin
The polyphenolic flavonoid quercetin that is found in fruit and vegetables shows unique bio-active properties, such as anti-cancer, anti-inflammation, anti-oxidant, and antiviral effects, which thus might play a role in health promotion and disease prevention, as well as in treatment [190][191][192]. Interestingly, previous studies have demonstrated that anti-oxidation methods reducing ROS could reduce the extent of tendon adhesion [193,194]. Furthermore, in a recent in vivo study by Liang et al., it has been demonstrated that quercetin treatment of rat tendon adhesion models can lead to increased anti-oxidant enzyme activity, as shown by enhanced levels of glutathione peroxidase and superoxide dismutase, while MDA levels were reduced in a concentration-dependent manner. In addition, histological analysis showed a lower extent of tendon adhesion in the rats treated with higher concentrations of quercetin, and no side effects or toxicity of quercetin therapy were observed [195].
Furthermore, Semis et al. found proof of quercetin exhibiting anti-inflammatory, anti-apoptotic, and anti-oxidant activity on rat tendon in vivo after collagenase-induced tendinitis. Moreover, inflammatory markers such as MMPs, ICAM-1, and STAT3 were activated by tendinitis induction, whereas all of them could be remarkably suppressed by quercetin administration, making it a promising agent for tendon damage protection [149]. In a study by Fu et al., quercetin has been investigated in combination with kaempferol and isorhamnetin as total flavones of sea buckthorn (Hippophae rhamnoides) for the healing of patellar tendon in rats. Within the study, it has been observed that the administration of the flavones not only improved the stress of healing tendons, especially at early stages, but also fiber alignment, collagen deposition, healing, and the recovery of the patellar tendon, suggesting that they could be effective for the improved recovery of tendon injuries (Table 1) [144].

Resveratrol
Resveratrol (Figure 4) is a polyphenolic compound that is found in a variety of plants, including grapes, peanuts, or mulberries. It has been reported as a health-beneficial agent with pharmacological activity positively affecting inflammation, ROS, cancer, diabetes, obesity, and other chronic diseases [117,128,[196][197][198][199][200][201]. Moreover, resveratrol has been found to play a role in the modulation of a wide range of cellular mechanisms and pathways, including growth inhibition, proliferation and differentiation, apoptosis, and inflammation cascades [14,62,71,202]. In addition, resveratrol, although its mode of action is not completely understood yet, is known to be a potent activator of Sirt-1; thus, it has a modulatory impact on the Sirt-1 signaling pathway [71,203,204] and acts as NF-κB inhibitor [101,205,206]. Furthermore, in the context of tendinitis, the potential of resveratrol to inhibit the NF-κB signaling pathway, induced by IL-1β and pro-inflammatory gene end products linked with it, has been observed in human tenocytes in vitro. Similarly, IL-1βpromoted PI3K activation has also been described to be suppressed in a dose-dependent manner by resveratrol treatment in tenocytes, comparable to the effects of PI3K inhibitors, suggesting PI3K as a main target signaling pathway of resveratrol in order to suppress NF-κB [14]. These anti-inflammatory effects of resveratrol in tenocytes are assumed to be partly associated with the linkage of Sirt-1 and scleraxis, as well as the deacetylation of NF-κB and PI3K [14,62]. In the same context, it has been demonstrated that resveratrol not only exhibited anti-inflammatory properties, but also stimulated the synthesis of collagens, tenomodulin, and tendon-specific transcription factor scleraxis, which is necessary for tissue vitality and regeneration [14]. The healing capabilities of resveratrol in tendon tissue have also been revealed in diabetic rats in vivo suffering from poor wound healing, following enhanced collagen production, vascular proliferation, and higher fibroblast density, which supported the healing process of Achilles tendinitis despite diabetic conditions [61]. Interestingly, in another in vitro study by Busch et al., the previously mentioned target of resveratrol, Sirt-1, was down-regulated in human tenocytes, leading to the expression of apoptotic proteins (Bax, caspase-3), the acetylation of p53 tumor suppressor Akt activation, and scleraxis suppression. Resveratrol could only inhibit IL-1β-induced NF-κB activation to down-regulate inflammatory mediators, such as COX-2 and MMP-9 in tenocytes, when Sirt-1 was expressed [62]. The role of Sirt-1 in association with resveratrol's anti-inflammatory effects has also been demonstrated in an in vivo study by Poulsen et al. whereby resveratrol prevented dexamethasone-induced senescence of tenocytes triggered by Sirt-1 inhibition [207]. As glucocorticoids are known to promote tendon senescence and collagen attenuation, the effect of resveratrol to activate Sirt-1, thus inhibiting inflammatory and tendon degrading processes, despite glucocorticoid treatment, is of great potential [29,30,208].
Moreover, in a recently conducted study, polydatin, a derivate of resveratrol, was found to exhibit anti-glycation effects in rat tail tendon in vitro. Glycation leads to AGE formation that causes molecular cross-linking of collagen, making it develop resistance to MMPs, leading to strongly reduced collagen turnover, in turn making collagen and tendon less flexible, and increasing the risk of tendinitis. AGE formation has been found to be accelerated by ROS; hence, resveratrol as a plant-derived anti-oxidant could be a potential natural anti-glycation agent for diabetes and could help to prevent diabetes accompanying disorders, such as tendinitis (Table 1) [209].  1 injection with 50 µL of hydrogel [146] [62] in vitro, human tenocytes Sirt-1 Resveratrol averted dexamethasone-induced senescence despite glucocorticoid treatment.

Anti-Inflammatory Effect of Nutraceuticals on Tendinitis in Clinical Trials
Currently, clinical trials investigating the effect of natural compounds on tendinitis in patients are rare. The nutraceuticals that have been studied in clinical trials in the context of tendinitis are Boswellia acid (BA) and curcumin, as concomitant agents to BA, as well as E. angustifolia and pineapple extracts.
Boswellia acid is the active ingredient derived from the Boswellia serrata tree and is found in its gum resin. BA has been used in the treatment of chronic inflammatory diseases, including bowel disease, asthma, and musculoskeletal disorders, in traditional Indian and African countries for centuries, and is known to have anti-inflammatory properties and to promote tissue regeneration [143,210,217,218]. To enhance the pharmacokinetic activity of BA, a lecithin-based system for its delivery called Casperome ® has been developed. Oral administration of Casperome ® was investigated in patients suffering from Achilles tendinitis and epicondylitis. On the one hand, the outcome of the study showed significant pain reduction of patients, and, on the other hand, tendon functionality of the injured area was strongly increased when Casperome ® was supplemented. Simultaneously, inflammation-linked markers in patients plasma were down-regulated, underscoring the anti-inflammatory potential of BA in tendon injury [210]. The described role of BA in the form of Casperome ® as a potential agent for pain relief and tissue regeneration in musculoskeletal disorders is supported by another clinical trial that examined the effects of Casperome ® on osteo-muscular pain triggered by inflammation of the knee tendon and joint. Here, the pain could be significantly reduced by daily oral BA supplementation together with standard therapy. However, significance of these outcomes is limited and has to be validated by larger scale investigations [211].
In another clinical trial that was conducted by Merolla et al., BA was used as a combinational therapy with the extracts of Curcuma longa (Tendisulfur ® ) that was orally administered concomitantly to analgesic treatment for the management of patients with supraspinatus injuries. Outcomes of Tendisulfur ® treatment were compared to patients, who did not receive Tendisulfur ® supplementation (placebo group). Within this study, Tendisulfur ® was found to be capable of reducing short-and mid-term post-operative pain, which in turn lead to a reduced intake of NSAIDs that is often accompanied by severe adverse effects, whereas long-term pain could not be alleviated by Tendisulfur ® supplementation. These results demonstrate the use of BA in combination with turmeric extracts, not only as a new strategy for post-operative pain relief, but especially as a good co-treatment strategy to reduce adverse effects accompanying the intake of NSAIDs. Altogether, Boswellia serrata and Curcuma longa extracts can be assumed to play an important role in new treatment or co-treatment strategies of tendinitis and its prevention [212]. This has also been shown in a clinical trial carried out by Henrotin et al., in which the combination of Boswellia serrata and Curcuma longa, in the form of pills, was used to analyze their effects on patients suffering from tendinopathies in a one-month trial. As described in the previous trial, this study's results clearly showed pain and symptom relief, as well as the alleviation of the functional limitation of tendon, whereas the administration was proven to be safe during the treatment period, further suggesting these nutraceuticals as potential agents in tendon treatment or as concomitant therapy, which comes with no or less side effects [65].
In another study that was conducted by the group of Notarnicola et al., pineapple extract bromelain, together with other dietary supplements, including arginine, collagen vitamin c, methyl-sulfonyl-methane, and Vinitrox™, was supplemented by patients suffering from Achilles tendinopathy, in combination with extracorporeal shock wave therapy (ESWT), to analyze pain reduction and joint function. In the control group, patients received ESWT without dietary supplement intake, i.e., the placebo. For clinical and functional evaluation, the visual analogue scale and the ankle-hindfoot scale, as well as the Roles and Maudsley scores, were used. The results showed pain and functional improvement in the experimental group receiving dietary supplements together with ESWT, indicating that bromelain, together with concomitant dietary components, can synergistically increase the efficiency of ESWT, in comparison to the placebo group. However, the general group size of patients was limited; thus, further studies using larger sample sizes are necessary to validate these outcomes [214].
A similar diet consisting of bromelain, arginine-L-ketoglutarate, methyl-sulfonatemethane, and hydrolysed collagen I was administered to patients with a large posteriorsuperior rotator cuff tear in a clinical trial by Gumina et al. for 3 months [215]. For reference, another group of patients was treated without dietary supplements. Outcomes were analyzed using a pre-and post-operative constant score, whereby repair integrity was evaluated by MRI via Sugaya's classification. In addition, results of pre-and post-operative simple shoulder tests were considered. Significant differences between the experimental group and the placebo group were mainly found in pain that was reduced with supplement administration and in integrity repair that was significantly improved in the same group. These results suggest bromelain in combinational administration for pain relief and better repair integrity in post-operative rotator cuff tendinopathy. The short follow-up period of this study and the small sample size demonstrate the limitations of these outcomes [215].
Moreover, in another clinical trial by Notarnicola et al., Echinacea angustifolia extracts were dietary-supplemented, combined with alpha lipoic acid and conjugated linoleic acid, which were used for the treatment strategy of carpal tunnel syndrome patients and compared to ESWT [216]. Echinacea angustifolia is known to exhibit strong antimicrobial, anti-inflammatory, and anti-oxidant properties, as well as immune-modulating activity [219,220]. These effects have previously been demonstrated to be partly exerted by modulation of major inflammatory pathways, including NF-κB and MAPK [220,221]. The study which compared the effects of Echinacea angustifolia containing dietary supplementation to ESWT treatment of carpal tunnel patients showed that both strategies revealed improvements in pain and functionality in a comparable manner, indicating the potential of nutraceuticals to be embedded in future treatment strategies, since they represent a comfortable method for the management of carpal tunnel syndrome and other tendinopathies [216].
Nutraceutical diets consisting of natural compounds Curcuma longa, Boswellia serrata, bromelain extracts and methyl sulfonyl methane, hydrolyzed collagen I and II, L-arginine, L-lysin, vitamin C, chondroitin sulfate, glucosamine, and myrrh (Tendisulfur ® Forte) were also analyzed in combination with ESWT in various tendinopathies, including lateral epicondylitis, Achilles, and rotator cuff tendinopathy in a clinical trial of Vitali et al. compared to patients undergoing ESWT without supplementary diet. The study's outcome supports results of similar studies, revealing faster pain relief in tendinitis patients by nutraceutical supplementation due to the suppression of inflammation, thus leading to reduced NSAID consumption (Table 1) [213].
Overall, clinical trials that have been carried out for better knowledge of the pharmaceutic activity of nutraceuticals in inflammation-triggered tendinitis showed promising outcomes of reduced pain and down-regulated inflammatory markers in patients, leading to reduced NSAID intake and functional improvement. However, the few clinical trials that are found in the context of nutraceuticals and tendinitis focus on Boswellia serrata and Curcuma longa, as well as pineapple extract bromelain in combination with other dietary components, although many more natural compounds have been found to act as antiinflammatory agents in pre-clinical studies [65,211,212,214,215]. Therefore, further clinical trials are urgently needed for validation of pre-clinical research of plant-derived tendinitis therapy in patients, and available results of clinical trials have to be verified in further studies with larger sample sizes. Nevertheless, existing data encourage further investigation on nutraceuticals as anti-inflammatory, tendon-protective, and pain-reducing agents.

Discussion and Perspectives
Tendon pathology is a common disease, accounting for around 30% of medical consultations because of musculoskeletal issues and pain [170]. Reasons underlying tendinitis pathologies are various, ranging from tendon rupture and mechanical overuse to a poor lifestyle and diet, as well as insufficient movement; however, in many cases, tendinitis is associated with and occurs in the most common inflammatory local and systemic diseases, such as rheumatoid arthritis, osteoarthritis, or spondyloarthritis [7,8,[222][223][224]. These disorders are often accompanied by swelling, unbearable pain of tendons, and severe limitation of joint mobility and functionality [223,225,226]. Current modern therapy for tendinitis is aimed at controlling the symptoms of the disease, mainly using NSAIDs and glucocorticoids [3,20]. However, these anti-inflammatory drugs only relieve pain and swelling in tendons, but simultaneously cause severe side effects on many organs when taken long-term, such as gastrointestinal, cardiovascular, hepatic, renal, cerebral, and pulmonary systems, and are also very expensive [22,25]. Moreover, their administration has even been found to be counterproductive in some cases, because of showing inhibitory effects on proteoglycan and collagen synthesis, as well as on tendon cell proliferation, which is crucial for the regeneration and healing of tendons [29,30,208].
For these reasons, treatment alternatives that act as effective and safe drugs, thus relieving tendinitis symptoms or at least delaying the progression of the disease, are necessary. Nutraceuticals and their active ingredients can interact as multi-targeting molecules in the cells of all tissues and are able to modulate the major mediators that are assumed to cause dysregulation of inflammatory pathways which are associated with severe chronic diseases, as shown in the context of tendon pathologies and tendinitis [10,33,36,170]. Simultaneously, different polyphenols are known to help strengthen and stabilize the immune response of the human organism, thus offering great potential for the prevention and prophylactic treatment of chronic diseases [16]. Moreover, in the administration of tested natural compounds, no toxic effects or side effects were observed so far as it is assessable, fulfilling another requirement that is relevant for the sustainable management of inflammatory diseases such as tendinitis. However, currently available evidence is limited and does not draw a definite conclusion on that. Moreover, most of the studies that have been carried out in the context of nutraceuticals and tendinitis comprise pre-clinical studies, and more clinical research considering long-term efficacy and safety, besides pharmacological activity of plant-derived nutraceuticals, is still needed. Furthermore, transferring in vitro to in vivo study models bears further challenges that necessarily should be considered, such as relatively high concentrations of polyphenolic agents in vitro, which are not inevitably appropriate for in vivo use, highlighting the importance of clinical trials for further evidence. In addition, with regard to the bioavailability of plant-derived compounds as nutraceuticals and their actual treatment efficiency in practice, further clinical studies are needed for better examination and, if necessary, improvements in their pharmacologic effects. Moreover, larger-scale studies and further extensive research can help to harness the potential of nutraceuticals and to find new ways to improve the treatment of patients with serious diseases such as tendinitis.

Conclusions
Altogether, plant-derived nutraceuticals offer a promising potential treatment option for inflammation-related diseases, such as tendinitis, which concomitantly act as great drivers of anabolic processes in tendon tissue, by modulating inflammatory mediators in a safe and efficient way. In addition, these effects, together with their immuno-beneficial characteristics, make them suitable agents in tendinitis prevention or co-treatment. Nevertheless, further extensive research covering pre-clinical as well as clinical trials is necessary to overcome current limitations and to validate current findings and future possibilities.

Conflicts of Interest:
The authors declare that they have no conflicts of interest.